All News

After cancer treatment, I wanted to go right back to living my life normally, but a fellow CURE blogger’s post reminded me that rest is necessary too.

From James Van Der Beek spreading awareness about colorectal cancer at a younger age to Gerry Connolly’s recent esophageal cancer diagnosis, here’s what’s happening in the cancer space this week.

The combination of Bavencio and gemcitabine showed promising efficacy and safety in certain patients with advanced leiomyosarcoma.

CURE partnered with City of Hope for a webinar to discuss focusing on quality of life when talking with care teams during breast cancer treatment.

In this on-demand webinar series, CURE partnered with City of Hope to discuss how patients with breast cancer can best communicate with their care team.

In this on-demand webinar series, CURE partnered with City of Hope to discuss effective communication when making treatment decisions for breast cancer.

Rates of colorectal cancer diagnoses and deaths are climbing among patients younger than 55, researchers have shown.

As a patient with chronic lymphocytic leukemia, I recently gleaned three new insights from my oncologist and phlebotomist.

In patients with relapsed or refractory multiple myeloma, KRd56 and KRd27 showed similar effectiveness and safety, but other treatment options may be better.

Induction chemotherapy shows significant improvements for survival in patients with locally advanced cervical cancer.

The accelerated approval of Trodelvy for patients with metastatic urothelial cancer has been voluntarily withdrawn.

My quality of life has improved a lot after starting on a BTK inhibitor, but some things will never be the same — like being in crowded places without a mask!

Patients with EGFR-mutant non-small cell lung cancer who are TKI-naïve benefited from receiving the Cyramza-Tagrisso combination versus Tagrisso alone.

Patients with muscle-invasive bladder cancer who underwent whole pelvis radiation showed improved cancer-specific survival and overall survival.

Chemotherapy for three months demonstrates lower side effects, suggesting its use as standard care compared with six months.

Expert answers to patients’ questions were offered as part of the CURE® Educated Patient® Prostate Cancer Summit.

Even if care teams have all of your information on their end, advocating for yourself is still necessary during cancer treatment.

Patients with cervical cancer demonstrated better sexual health and quality of life after undergoing simple hysterectomies versus radical hysterectomies.

The CAR-T cell therapy Carvykti has been shown to be effective among patients outside the confines of a clinical trial.

Ameluz-photodynamic therapy in superficial basal cell carcinoma may improve the clearance of target lesions, as shown in early data from a phase 3 trial.

Perioperative chemoimmunotherapy for resectable non-small cell lung cancer (NSCLC) shows promising long-term benefits with minimal side effects.

I once thought that prostate cancer should be the center of my universe, but with everything else going on, now I’m not so sure.

Among patients with polycythemia vera, the treatment pairing of Jakafi and Pegasys shows benefits with acceptable toxicity, research showed.

The phase 2 INVINCIBLE-4 clinical trial is currently underway in patients with localized triple-negative breast cancer.

A colleague wrote about a dedicated oncology nurse who excels in patient care, demonstrates exceptional clinical skills and consistently goes above and beyond to improve patient outcomes.

An expert explained how sentinel lymph node biopsy has helped surgeons remove fewer lymph nodes, which can reduce lymphedema risk in patients with breast cancer.

I initially put off a colonoscopy due to gastroesophageal reflux disease, but after a positive home screening test, I underwent the procedure and was diagnosed with stage 3 rectal cancer.

The FDA received the New Drug Application for avutometinib plus defactinib as a potential treatment option for previously treated low-grade serous ovarian cancer.

During October, the FDA approved drugs to treat diseases including breast cancer, lung cancer, leukemia and gastric cancer.

After my breast cancer diagnosis, I decided to take a more active role in my treatment plan, opting for radiation therapy over chemotherapy due to concerns about side effects.